Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuo Fujihara

Showing results (11-20 of 292) with videos related to

Pageof 30
Sort By:
Brain and Nerve = Shinkei Kenkyu No Shinpo|October 7, 2024
[Efficacy and Safety of Inebilizumab, an Anti-CD19 Monoclonal Antibody, for the Treatment of Neuromyelitis Optica Spectrum Disorder: Based on the N-MOmentum Trial]Kazuo Fujihara, Hirokazu Sato
Nature Reviews. Neurology|November 12, 2014
Neuroimmunology: towards more-accurate diagnosis in neuromyelitis opticaKazuo Fujihara, Jacqueline Palace
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 21, 2015
[Current and historical concept of neuromyelitis optica]Toshiyuki Takahashi, Kazuo Fujihara
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?Kazuo Fujihara, Ichiro Nakashima
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 20, 2013
[Pathogenesis of neuromyelitis optica]Tatsuro Misu, Kazuo Fujihara
Arquivos De Neuro-Psiquiatria|November 2, 2011
Atypical presentations of neuromyelitis opticaDouglas Sato, Kazuo Fujihara
Neurology|December 16, 2014
AQP4 in biopsied demyelinating lesions as a diagnostic clue to NMOSD and MS: final answer?Kazuo Fujihara, Tatsuro Misu
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 5, 2012
[Cognitive impairment in demyelinating disease]Juichi Fujimori, Kazuo Fujihara
Brain and Nerve = Shinkei Kenkyu No Shinpo|June 8, 2019
[Current Status and Prospects of Complement-Targeting Therapy for Neuromyelitis Optica]Hiroshi Kuroda, Kazuo Fujihara
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 2, 2010
Neuromyelitis optica without typical opticospinal phenotypeDouglas Sato, Kazuo Fujihara
Pageof 30

Showing results (11-20 of 292) with videos related to

Sort By:
Pageof 30
Brain and Nerve = Shinkei Kenkyu No Shinpo|October 7, 2024
[Efficacy and Safety of Inebilizumab, an Anti-CD19 Monoclonal Antibody, for the Treatment of Neuromyelitis Optica Spectrum Disorder: Based on the N-MOmentum Trial]Kazuo Fujihara, Hirokazu Sato
Nature Reviews. Neurology|November 12, 2014
Neuroimmunology: towards more-accurate diagnosis in neuromyelitis opticaKazuo Fujihara, Jacqueline Palace
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 21, 2015
[Current and historical concept of neuromyelitis optica]Toshiyuki Takahashi, Kazuo Fujihara
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?Kazuo Fujihara, Ichiro Nakashima
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 20, 2013
[Pathogenesis of neuromyelitis optica]Tatsuro Misu, Kazuo Fujihara
Arquivos De Neuro-Psiquiatria|November 2, 2011
Atypical presentations of neuromyelitis opticaDouglas Sato, Kazuo Fujihara
Neurology|December 16, 2014
AQP4 in biopsied demyelinating lesions as a diagnostic clue to NMOSD and MS: final answer?Kazuo Fujihara, Tatsuro Misu
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 5, 2012
[Cognitive impairment in demyelinating disease]Juichi Fujimori, Kazuo Fujihara
Brain and Nerve = Shinkei Kenkyu No Shinpo|June 8, 2019
[Current Status and Prospects of Complement-Targeting Therapy for Neuromyelitis Optica]Hiroshi Kuroda, Kazuo Fujihara
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 2, 2010
Neuromyelitis optica without typical opticospinal phenotypeDouglas Sato, Kazuo Fujihara
Pageof 30